SAN FRANCISCO (GenomeWeb) – Adaptive Biotechnologies plans to become "the global leader" in immune profiling and designing customized therapeutics, according to CEO and Cofounder Chad Robins.
SAN FRANCISCO (GenomeWeb) – Adaptive Biotechnologies plans to become "the global leader" in immune profiling and designing customized therapeutics, according to CEO and Cofounder Chad Robins.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.